2025 International Congress Archives - Page 174 of 181

Unraveling the Variability in Amantadine Response for Levodopa-Induced Dyskinesias: The Impact of Clinical and Genetic Factors

L. Saadatpour, H. Chaparro-Solano, J. Yu, C. Sonneborn, C. Piccinin, S. Anis, E. Assaedi, P. Coss, S. Horn, O. Vaou, I. Mata, H. Fernandez (San Antonio, USA)
Unravelling The Relationship Between Autonomic Nervous System And Anxiety In People With Parkinson’s Disease

L. Ricciardi, A. Fanciulli, F. Cucinotta, B. Ishahara, I. Cociasu, F. Baig, E. Pereira, M. Hart, F. Morgante, E. Makovac (London, United Kingdom)
Unsupervised Analysis and Clustering of 3D Parkinsonian Gait

S. Lyu, KD. Kim, T. Dunn (Durham, USA)
Unusual presentation of POLR3A-associated leukodystrophy – two cases reported

N. Mazalica, A. Milovanovic, M. Sarcevic, A. Tomic, V. Markovic, M. Brankovic, A. Marjanovic, N. Dragasevic-Miskovic (Belgrade, Serbia)
Unveiling a rare case: Novel TBK1 variant presenting as Multiple system atrophy-like phenotype

R. Kandadai, M. Karri, S. Kola, R. Borgohain, R. Alugolu, P. Vvsrk, A. Nalamasa (Hyderabad, India)
Unveiling Parkinson’s Disease Variants in the Chinese Population: The CPD10KGP Study

Y. Zhao, Z. Liu, H. Pan, J. Guo, B. Tang (Changsha, China)
Unveiling the Molecular Mechanism of Polydatin in Ameliorating Parkinson’s Disease via the DRD2/CRYAB/NF-κB Axis in Astrocytes and Exploring Cell Therapy Strategies

SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)
Updated Meta-analysis Assessing GLP-1 Agonists for Parkinson’s Disease

M. Messak, A. Abdelmageed, Y. Khattab (Helwan, Egypt)
Updates on Perception of Patients with Cervical Dystonia in Residents and Medical Students

M. Patel, D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, P. Sheehan, A. Memon, M. Moreno-Escobar, A. Murray, G. Pawar, J. Frey (Morgantown, USA)
Upper Limb Tremor Suppression Using Targeted High Frequency Peripheral Nerve Stimulation

V. Ganesh, X. Xue, D. Roque, N. Sharma (Raleigh, USA)